IRF4 and leukemia: In contrast to other studies, we observe higher transcript levels in patients characterised by a more immature immunophenotype, and in T-cell leukemias than in leukemias of the B-lineage, implying that in childhood leukemia, IRF4 gene expression is not subject to the feedback regulation mechanisms that operate in normal tissues.